摘要
背景:阿尔兹海默病(AD)是一个严重复杂的神经组织退化性疾病。目前,全球约有4千4百万人患有AD,并且由于人口变化这个数据将成倍增加。这种疾病可以通过药物途径和非药物途径治疗。不幸的是,至今无法治愈。尽管如此,治疗AD的药物仍然很昂贵、有不同的副作用并且只能延迟这种疾病的症状。因此,研究者建议使用各种非药物疗法。除了西方国家相对受欢迎的像身体活动、意识训练或者健康膳食等方法,中药治疗在开始欧洲可行 目的:这篇简短的回顾主要为了讨论中药的概念同时从治疗AD中探索他最普遍有效的形式。 方法:通过在世界数据库像科学网、Scopus、PubMed和Springer中搜索文献。 结果:我们讨论分析了五个随机对照临床实验。 结论:这篇简短回顾的作者列出了中药治疗AD的优势(像回顾从随机对照临床实验中得出提高AD患者意识衰退的研究方面的积极效果)和不足(像在欧洲传统中医药的较低的利益意识)的表格。
关键词: 阿尔兹海默病,中药,概念,发现,受益,局限。
Current Alzheimer Research
Title:Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review
Volume: 14 Issue: 6
关键词: 阿尔兹海默病,中药,概念,发现,受益,局限。
摘要: Background: Alzheimer´s disease (AD) is a serious and complex neurodegenerative disease. Currently, there are about 44 million people suffering from AD all over the world and this number is expected to rapidly grow due to demographic changes. The disease can be treated both pharmacologically and non-pharmacologically. Unfortunately, it cannot be cured yet. Nevertheless, the drugs for the treatment of AD are quite expensive, have different side effects and only delay symptoms of this disease. Therefore researchers suggest the use of various non-pharmacological therapies. Apart from relatively popular in western world such as physical activities, cognitive training or healthy diet, Chinese medicine starts to be practiced in Europe.
Objective: The purpose of this mini-review is to discuss the concept of Chinese medicine and explore its most common and effective forms in the treatment of AD. Methods: This was done by conducting a literature search in the world´s acknowledged databases such as Web of Science, Scopus, PubMed and Springer. Results: Five randomized controlled clinical trial studies were analyzed and their findings were discussed. Conclusion: The authors of this mini-review list the key benefits (e.g., positive results of the reviewed randomized clinical trials studies for the improvement of cognitive decline in AD) and limitations (e.g., low awareness of benefits of TCM in Europe) of Chinese medicine therapy for the treatment of AD.Export Options
About this article
Cite this article as:
Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review, Current Alzheimer Research 2017; 14 (6) . https://dx.doi.org/10.2174/1567205014666170117103656
DOI https://dx.doi.org/10.2174/1567205014666170117103656 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Intracellular Signaling and Approaches to the Treatment of Schizophrenia and Associated Cognitive Impairment
Current Pharmaceutical Design Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease
Current Neuropharmacology A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in In Vitro SH-SY5Y Cells
Current Alzheimer Research Ischemia-Reperfusion Injury of the Cochlea: Pharmacological Strategies for Cochlear Protection and Implications of Glutamate and Reactive Oxygen Species
Current Neuropharmacology Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation
Current Alzheimer Research Herbals and Natural Dietary Supplements in Psychiatric Practice
Recent Patents on CNS Drug Discovery (Discontinued) Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Current Neuropharmacology Vitamins and Cognition: A Nutrigenomics Perspective
Current Nutrition & Food Science Hybrid Therapy in the Management of Atrial Fibrillation
Current Cardiology Reviews Metabolic Syndrome and Non-Cardiac Vascular Diseases: An Update from Human Studies
Current Pharmaceutical Design Neuro-Psychological Pattern in Patients Suffering from Primitive Dilated Cardiomyopathy with Impairment in Executive Function
Current Neurovascular Research Epilepsy, Comorbidities and Treatments
Current Pharmaceutical Design Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives
Current Pharmaceutical Design Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 Monoclonal Antibodies
Current Medicinal Chemistry RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders
Current Medicinal Chemistry Risk-Benefit Perspectives in COX-2 Blockade
Current Drug Safety Acetylcholinesterase Imaging: Its Use in Therapy Evaluation and Drug Design
Current Pharmaceutical Design Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries
CNS & Neurological Disorders - Drug Targets Is a "Mitochondrial Psychiatry" in the Future? A Review
Current Psychiatry Reviews Peripheral Mononuclear Cell Rejuvenation for Senescence Surveillance in Alzheimer Disease
Current Pharmaceutical Design